STM publisher Elsevier, Netherlands, has announced that the Cancer Genetics and Cytogenetics journal is changing its title to Cancer Genetics. The journal has also named Dr. Jaclyn A. Biegel as editor-in-chief.
The changes reflect broader aims and scope for the journal with a new focus on diagnostic applications as well as the genetic predisposition of cancer. The initiative marks an important move by Elsevier to provide the STM community with a wider variety of original, clinically relevant information for the diagnosis, prognosis and risk evaluation of cancer patients and a greater understanding of how altered gene regulation will ultimately lead to new, targeted therapies for treatment. The first issue of Cancer Genetics will be published in January 2011, with a new cover and interior design.
Editor-in-Chief Dr. Jaclyn A. Biegel is the Director of the Cancer Cytogenetics Laboratory at the Children's Hospital of Philadelphia and a Professor of Pediatrics at the University of Pennsylvania School of Medicine. Her clinical expertise is in the diagnosis of pediatric leukemia and solid tumors. Her research expertise is in the genetics of pediatric brain tumors and rhabdoid tumors.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
